Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania Rossi

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Biological Chemistry|November 15, 2024
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterationsValentina Masciale, Federico Banchelli, Giulia Grisendi, et al.
Frontiers in Molecular Biosciences|November 25, 2021
Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast CancerErika Bandini, Tania Rossi, Emanuela Scarpi, et al.
Molecular Therapy. Methods & Clinical Development|June 5, 2023
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive valueIvan Vannini, Tania Rossi, Mattia Melloni, et al.
Experimental Hematology & Oncology|May 6, 2025
Transcriptomic profiling of circulating tumor cells from metastatic breast cancer patients reveals new hints in their biological features and phenotypic heterogeneityTania Rossi, Sara Bandini, Michele Zanoni, et al.
Cell Death & Disease|March 29, 2025
Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferationTania Rossi, Martina Valgiusti, Maurizio Puccetti, et al.
Journal of Translational Medicine|June 22, 2018
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patientsSerena De Matteis, Chiara Molinari, Giulia Abbati, et al.
Cancer Letters|November 22, 2024
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profilingLorenzo Gerratana, Andrew A Davis, Lorenzo Foffano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2024
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primaryAndrea Cavazzoni, Irene Salamon, Claudia Fumarola, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Biological Chemistry|November 15, 2024
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterationsValentina Masciale, Federico Banchelli, Giulia Grisendi, et al.
Frontiers in Molecular Biosciences|November 25, 2021
Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast CancerErika Bandini, Tania Rossi, Emanuela Scarpi, et al.
Molecular Therapy. Methods & Clinical Development|June 5, 2023
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive valueIvan Vannini, Tania Rossi, Mattia Melloni, et al.
Experimental Hematology & Oncology|May 6, 2025
Transcriptomic profiling of circulating tumor cells from metastatic breast cancer patients reveals new hints in their biological features and phenotypic heterogeneityTania Rossi, Sara Bandini, Michele Zanoni, et al.
Cell Death & Disease|March 29, 2025
Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferationTania Rossi, Martina Valgiusti, Maurizio Puccetti, et al.
Journal of Translational Medicine|June 22, 2018
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patientsSerena De Matteis, Chiara Molinari, Giulia Abbati, et al.
Cancer Letters|November 22, 2024
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profilingLorenzo Gerratana, Andrew A Davis, Lorenzo Foffano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2024
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primaryAndrea Cavazzoni, Irene Salamon, Claudia Fumarola, et al.
Pageof 3